Presentation is loading. Please wait.

Presentation is loading. Please wait.

ENTERIC FISTULAS IN THE NAME OF GOD 1. ENTERIC FISTULAS represent a second group of complex intraperitoneal infectious processes. Mortality remains high,

Similar presentations


Presentation on theme: "ENTERIC FISTULAS IN THE NAME OF GOD 1. ENTERIC FISTULAS represent a second group of complex intraperitoneal infectious processes. Mortality remains high,"— Presentation transcript:

1 ENTERIC FISTULAS IN THE NAME OF GOD 1

2 ENTERIC FISTULAS represent a second group of complex intraperitoneal infectious processes. Mortality remains high, between l0-30% in recent series. largely due to the frequent complications of sepsis and malnutrition. Electrolyte imbalances, as a third key factor leading to mortality 2

3 CLASSIFICATION Classified by: the anatomy of the stnrctures involved the amount and composition of drainage the etiology responsible for their formation In addition to classification,these distinctions may provide important prognostic information about the physiologic impact of fistulas and the likelihood that they will close without surgical resection,the principal decision confronting the responsible surgeon. 3

4 ETIOLOGIC CLASSIFICATION Enterocutaneous fistulas result from several processes:  (1) diseased bowel extending to surrounding structures  (2) extraintestinal disease involving otherwise normal bowel  (3) trauma to normal bowel including inadvertent or missed enterotomies  (4) anastomotic disruption following surgery for a variety of conditions Fistulas between the alimentary tract and skin may be classified as postoperative or spontaneous. 4

5 ETIOLOGIC CLASSIFICATION  Approximately three-quarters of fistulas occur following: an operation,most commonly subsequent to procedures performed for malignancy, inflammatory bowel disease, or adhesions 5

6 ETIOLOGIC CLASSIFICATION Patient factors that increase the likelihood of developing a postoperative fistula include:  Malnutrition  Infection  emergency operations with concomitant hypotension, anemia, hypothermia,and poor oxygen delivery 6

7 If possible, these conditions should be corrected prior to operation, but in emergency situations, optimization of resuscitation and performance of a technically meticulous procedure including adequate mobilization, good quality bowel with good blood supply, and no tension will provide the best chance of a good outcome. ETIOLOGIC CLASSIFICATION 7

8 Postoperative enterocutaneous fistulas result from:  either disruption of the anastomosis  inadvertent (and often unrecognized) bowel injury during the dissection or abdominal closure  Attention to avoidance of tension or ischemia in the creation of anastomoses is paramount in minimizing postoperative enterocutaneous fistulas. The remaining 25 percent of fistulas do not occur following a surgical procedure. 8

9 spontaneous fistulas spontaneous fistulas often develop in:  patients with cancer  Following radiation therapy  Fistulas occurring in the setting of malignancy or Irradiation are unlikely to close without operative intervention.  Inflammatory conditions such as:  inflammatory bowel disease  diverticular disease  perforated ulcer disease  Ischemic bowel 9

10 Of these, fistulas in patients with inflammatory bowel disease are most common; these fistulas often close following a prolonged period of parenteral nutrition, only to reopen when enteral nutrition resumes. An understanding of the etiology of an enterocutaneous fistula may provide information about the ultimate need for surgical intervention. spontaneous fistulas 10

11 ANATOMIC CLASSIFICATION Fistulas may communicate with  the skin (external fistulas)  or other intraperitoneal  or intrathoracic organs (internal fistulas) 11

12 Internal fistulas that bypass only short segments of bowel may not be symptomatic; however,internal fistulas of bowel that bypass significant length of bowel or that communicate with either the bladder or vagina typically cause symptoms and become clinically evident. However,internal fistulas of bowel that bypass significant length of bowel or that communicate with either the bladder or vagina typically cause symptoms and become clinically evident. The identification and management of internal fistulas is beyond the scope of this ANATOMIC CLASSIFICATION 12

13 ANATOMIC CLASSIFICATION internal fistulas should be resected if :  they are symptomatic  cause physiologic or metabolic complications 13

14 Small bowel fistulas.The majority of gastrointestinal cutaneous fistulas arise from the small intestine. Seventy to ninety percent of enterocutaneous fistulas occur in the postoperative period. postoperative small bowel fistulas result from either disruption of anastomoses or injury to the bowel during dissection or closure of the abdomen. Operations for cancer in flammatory bowel disease, and adhesiolysis are the most common procedures antecedent to small bowel fistula formation. 14

15 During the course of a procedure, resection with end-to-end anastomosis is recommended for small bowel defects and injuries, especially when simple closure would be expected to reduce the luminal diameter. All sersosal injuries should be repaired with intermpted 3-0 silk sutures. Spontaneous small bowel fistulas arise from inflammatory bowel disease, cancer, peptic ulcer disease, or pancreatitis. Crohn's disease is the most common cause of spontaneous small bowel fistula. The transmural inflammation underlying Crohn's disease may lead to adhesion of the small bowel to the abdominal wall or other abdominal structures. Small bowel fistulas 15

16 Microperforation may then cause absces formation and erosion into adjacent structures or the skin. Roughly half of Crohn's fistulas are internal and half are external. crohn's fistulas tpyically follow one of two courses:  The first type represents fistulas that present in the early postop_ erative period following resection of a segment of diseased bowel. These fistulas arise in otherwise healthy bowel and follow a course similar to non-Crohn's fistulas with a significant likelihood of sponta_ neous closure.  The other group of Crohn's fistulas arises in diseased bowel and has a low rate of spontaneous closure. Small bowel fistulas 16

17 Additionally, should spontaneous closure occur, these fistulas often reopen upon resumption of enteral intake. Early operative closure of these fistulas should be considered. Small bowel fistulas 17

18 Colonic fistulas Spontaneous fistulas of the colon result from diverticulitis, malignancy, inflammatory bowel disease, appendicitis, and pancreatitis, while treatment of these conditions accounts for the majority of postoperative colocutaneous fistulas. Anastomotic breakdown or extension from inadequately resected disease bowel account for the majoriry of the postoperative fistulas. Additionally,with gastrocutaneous fistulas, an increased incidence of colocutaneous fistulas has been reported following percutaneous gastrostomy placement. 18

19 Appendiceal fistulas may result from drainage of an appendiceal abscess or appendectomy in a patient with Crohn's disease. the fistula often originates from the terminal ileum, not the cecum. The inflamed ileum adheres to the abdominal wall closure and sub_ sequently results in fistula formation. Erosion of a percutaneous drain for spontaneous right lower quadrant abscess is also an increasing cause of gastrointestinal cutaneous fistula in Crohn's disease. Radiation therapy contributes to both spontaneous and postoperative colocutaneous fistulas. Colonic fistulas 19

20 Techniques to provide additional protection and blood supply to anastomoses performed under these conditions include coverage of anastomoses with omentum, filling of dead space with muscle flaps, or sigmoid exclusion. proximal diverting colostomy or ileostomy may allow sufficient anastomotic healing prior to sutureline challenge with luminal contents. Operation or reoperation in an irradiated field is subject to recurrence of colocutaneous fistulas, and these fistulas are unlikely to undergo spontaneous closure. Colonic fistulas 20

21 Fistula tract characteristic addition to describing the organs involved in fistulas, anatomic characteristics of fistula tracts may also be helpful in determining prognosis (Table 7-2). Due to anatomic considerations and the nature of effluent from different sites in the enteric tract, certain locations are more likely to undergo spontaneous closure. These favorable types include oropharyngeal, esophageal, duodenal stump, and jejunal fistulas. Unfavorable sites include the stomach, lateral duodenum, ligament of Treitz,and ileum. 21

22 Fistula tract characteristic 22

23 Anatomic factors suggesting low likelihood of spontaneous closure include fistulas associated with large abscesses, intestinal wall defects of greater than 1 cm, intestinal discontinuity, distal obstruction, diseased adjacent bowel, and fistulous tracts of less than 2 cm (Fig 7-5). In contrast, fistulas with intestinal wall defects less than 1 cm and longer tracts are more likely to undergo spontaneous closure. Fistula tract characteristic 23

24 Fistula tract characteristic 24

25 25

26 Physiological classification Enterocutaneous fistulas cause the loss of fluid, minerals,trace elements, and protein, as well as allow the release of irritating and caustic substances onto the skin and subcutaneous tissues. Accurate measurement of both the amount and nature of enteroCutan_ eous effluent allows for accurate replacement and an understanding of the physiologic and metabolic challenges to the patient (Table 7-3). Fistulas may be divided into high-output (>500 mL per day), moderate-output ( mL/day), and low-output (<200 mL/day) groups. 26

27 Physiological classification 27

28 Classification of enterocutaneous fistulas by the amount of daily output provides information regarding mortality, and in recent series may predict spontaneous closure. the classic series of Edmunds and associates, patients with high-output fistulas had a mortality rate of 54%, compared to a l6% mortality rate in the low-output group. More recently,Lervy and colleagues reported a 50% mortality rate in patients with high-output fistulas, while those with low-output fistulas had a 26% mortality. Physiological classification 28

29 In the largest series reported to date, Soeters and coworkers reported no association between fistula output and rate of spontaneous closure, while multivatiate analysis by Campos and associates suggested that patients with low-output fistulas were three times more likely to achieve closure without operative intervention. The reason for these different rates of closure is that high-output fistulas are likely to be of small-bowel origin,while low-output fistulas are likely to be of colonicorigin. Moderate-volume fistulas tend to be of either colonic or mixed small- and large-bowel origin (seeTable 7-2). Physiological classification 29

30 Prevention Proper preoperative patient preparation and meticulous surgical technique will lessen the risk of postoperative fistula formation. In the elective setting, operation may be delayed to allow for normali_ zaion of nutritional parameters, thus optimizing wound healing and immune function. Several nutritional characteristics have been suggested to increase the risk of anastomotic breakdown: 1. Weight loss of 10-15% of total body weight over 3-4 months 2. Serum albumin less than 3 mg/dL 3. Serum transferrin less than 220 mg/dL 4. Anergy to recall antigens 5. Inability to perform activities of daily living due to weakness or fatigue. 30

31 Mechanical and antibiotic bowel preparation reduce the amount of particulate fecal material as well as colonic bacterial counts. In practice, mechanical bowel preparation for elective colon operations combined with systemic antibiotics with activity against enteric organisms provides adequate prophylaxis. Prevention 31

32 In emergency operations, delays for optimization of nutritional status and bowel preparation are not possible. Instead, emphasis should be on adequate resuscitation and restoration of circulating volume, normalization of hemodynamics, provision of appropriate antibiotic therapy,and meticulous surgical technique Performance of anastomoses in a healthy, well-perfused bowel without tension provides the best chance for healing, especially when one can easily see the performance of the anastomosis clearly. Careful hemostasis to avoid postoperative hematoma formation will decrease the risk of abscess Prevention 32

33 while inadvertent enterotomies and serosal injuries should be identified and repaired. If possible, an omental flap should be used to separate the anastomosis from the abdominal incision. Secure abdominal wall closure using healthy tissue and care to avoid injury to the underlying bowel are important to prevent postoperative fistula formation. In the postoperative period, further resuscitation may be required to ensure hemodynamic stability and avoid inadequate tissue oxygenation. It is essential to avoid periods of transient postoperative hypotension related to the anesthesia. Prevention 33

34 Diagnosis,Evaluation and Manegment Regardless of the etiology or specific nature of the fistula,the ultimate goals in treating patients with enterocutaneous fistula are the re- establishment of bowel continuity,the ability to achieve oral nutrition, and the closure of the fistula. Given the metabolic and septic physiology often present with entero_ cutaneous fistulas, recognition of the development of an enterocu_ taneous fistula should prompt aggressive resuscitation and stabilization of the patient. 34

35 Drainage of obvious septic sources must be undertaken and nutritional support commenced Nutritional support should be delayed 24 hours for drainage, as hematogenous seeding of the catheter may result in catheter sepsis. If an abscess is pointing, one should do a fistulogram through the abscessb efore open drainage, using an angiocath to see where the water-soluble dye tracks to. Diagnosis,Evaluation and Manegment 35

36 This information in combination with the patient's response to nonoperative measures determines the length of time before operative intervention is performed. If surgery is required, meticulous technique in combination with a well- prepared team approach will optimize the likelihood of a successful patient outcome. Operative closure of the fistula does not end the surgical team's obligation to the patient, as continued nutritional support and physical and emotional rehabilitation are often required to return the patient to his or her pre-illness state. As in any complicated illness, care of the patient with an enterocutan_ eous fistula can be divided into several phases (Table 7-4). Diagnosis,Evaluation and Manegment 36

37 Diagnosis,Evaluation and Manegment 37

38 38

39 Phase1:Recognition and Stabilization 39

40 The combined insults of the preoperative disease process,a bowel preparation, a week of minimal nutritional support, and a septic state often results in a profoundly volume-depleted patient. The first stage in management of the fistula patient, therefore, is the restoration of volume using crystalloid and colloid products as appropriate to restore oxygen-carrying capacity and plasma oncotic pressure. Several liters of crystalloid are usually required to replace fluid lost into the bowel and bowel wall. Phase1:Recognition and Stabilization 40

41 while maintenance of a specific target hematocrit is controversial, blood should be transfused to support oxygen-carrying capacity to a hematocrit of at least 30%. Similarly, albumin may aid in wound healing and intestinal functionoa and is involved in the transport of certain nutrients and medications Administration of albumin to a serum level of 3.0 mg/dL supports these functions. Phase1:Recognition and Stabilization 41

42 Phase1:Recognition and Stabilization 42

43 Percutaneous drainage of collections in nonseptic patients should also be performed. Placement of central venous catheters for parenteral nutrition should be delayed for 24 hours following drainage of septic foci, as bacteremia following these procedures may seed catheters, leading to line sepsis. The use of antibiotics in patients with enterocutaneous fistulas should be reserved for specific indications. Most large series of patients with fistulas demonstrate that patients received seven to nine antibiotics during their treatment. in order to avoid selecting for resistant organisms, antibiotics should only be given for defined infections and for a set duration of therapy. Phase1:Recognition and Stabilization 43

44 Phase1:Recognition and Stabilization 44

45 Phase1:Recognition and Stabilization 45

46 This tube is soft at body temperature and will not erode into the bowel or abdominal wall structures. Accurate recording of fistula output is facilitated by this drainage system. More recendy, vacuum assisted closure (VAC) devices have been reported to both aid in the care of these complicated wounds and promote nonoperative closure( Fig 7-7). Phase1:Recognition and Stabilization 46

47 Phase1:Recognition and Stabilization 47

48 while there are no large series or randomized trials of the use of these devices in the management of enterocutaneous fistula, VAC dressings provide another option for wound care in these patients. The disadvantage of VAC dressings is the amount of time necessary to change these dressings, often hours. However, these dressings need only bechanged every 5 or so days. Phase1:Recognition and Stabilization 48

49 Phase1:Recognition and Stabilization 49

50 Reduction in acid secretion will also aid in the prevention of gastric and duodenal ulceration as well as decrease the stimulation of pancreatic secretion. Sucralfate, a mucosal protective agent, may also reduce gastric acidity while also providing a constipating action that may decrease fistula output as well As inhibitors of the secretion of many gastrointestinal hormones inclu_ ding gastrin, cholecystokinin, secretin,insulin, glucagons, and vasoactive peptide. it has been hoped that somatostatin and octreotide may reduce time to closure and promote nonoperative closure of enterocutaneous fistulas. Phase1:Recognition and Stabilization 50

51 Somatostatin and its analogue octreotide may be used to reduce gastrointestinal secretions, fistula output, and time to closure; however, data that demonstrate an effect on the rate of nonoperative closure of enterocutaneous fistulas are lacking. potential side effects of the use of these agents include difficult glucose homeostasis and cholelithiasis. Large prospective, randomized trials are needed to further clarify the role of somatostatin and octreotide in the management of enterocu_ taneous fistulas. Octreotide may accelerate closure of pancreatic fistulas. Phase1:Recognition and Stabilization 51

52 however Infliximab, a monoclonal antibody to tumor necrosis factor- alpha, has been shown to be beneficial in inflammatory and fistulizing inflammatory bowel disease. Use of infliximab in patiens with fistulas following ileal pouch-anal anastomosis for ulcerative colitis resulted in clinical response in six of seven patients and fistula closure in five patients after three treatments. In a study of 100 patients with fistulizing Crohn's disease, infliximab infusion resulted in complete response in 50 patiens,partial response in 22 patients, and no response in 28 patients. Phase1:Recognition and Stabilization 52

53 In a randomized trial of patients with chronic fistulas (duration greater than 3 months), administration of infliximab resulted in a significantly increased rate of closure of all fistulas when compared to placebo. Adverse events in these trials were largely infectious complications, including abscess formation, pneumonia,varicella zoster, Candidn esophagitis, and upper respiratory tract infection. Evidence suggests a role of infliximab in treatment of fistulas compli_ cating inflammatory bowel disease; whether this agent will be of use in patiens without Crohn's disease or ulcerative colitis remains to be determined. Phase1:Recognition and Stabilization 53

54 Phase1:Recognition and Stabilization 54

55 Patients with postoperative enterocutaneous fistulas are often mal_ nourished due to a combination of poor enteral intake, the hypercat_ abolic septic state, and the loss of protein-rich enteral contents through the fistula. Proper nutrition may improve immune function, provide protein precursors for wound healing, and sup port the functions of the gastro_ intestinal tract. Phase1:Recognition and Stabilization 55

56 As a general guideline, we provide 25-32kilocalories per kilogram per day with a calorie:nitrogen ratio of 150:1 to 100:1 and at least 1.5 grams per kilogram per day of protein. These are general principles of nutritional management and ongoing reassessment of each patient's clinical and laboratory values are required to optimize support for these complex patients. Parenteral nutrition has long been the corner_stone of support for patients with enterocutaneous fistu1as.. Phase1:Recognition and Stabilization 56

57 Transition to partial or total enteral nutrition has been advocated in recent reports to prevent atrophy of gastrointestinal mucosa as well as support the immunologic and hormonal functions of the gut and liver. Additionally, parenteral nutrition is expensive and requires dedicated nursing care to prevent undue morbidity and mortality from line insertion,catheter sepsis, and metabolic complications Phase1:Recognition and Stabilization 57

58 Enteral feeding may occur per os, via feeding tubes placed nasogas_ trically or nasoenterically, or via the fistula itself (i.e., fistuloclysis). Enteral support typically requires 4 feet of small intestine and is contraindicated in the presence of distal obstruction. Drainage from the fistula may be expected to increase with the commencement of enteral feeding; however, spontaneous closure may still occur, often preceded by a decrease in fistula output. Phase1:Recognition and Stabilization 58

59 Eleven of twelve patients were able to discontinue parenteral support and nutritional status was maintained until surgery in nine patients (19_422days) and for at least 9 months in the two patients who did not undergo operative intervention. Of note, surgeons in this study also reported improved bowel caliber, thickness, and ability to hold sutures in patients who had received enteral nutrition Phase1:Recognition and Stabilization 59

60 Phase2:Investigation Once the patient has been stabilized with control of sepsis and comme- ncement of nutritional support, investigation into the course and character of the fistula should be undertaken. This typically occurs 7-10 days after the identification of the fistula and allows time for the fistula tract to mature to the point where catheters can be placed in all orifices. Careful fistulography with water-soluble contrast provides information not obtainable through any other means. The senior surgeon responsible for the patient's care should be present with the most-senior available radiologist for the performance of the study. 60

61 Particular attention should be paid to the length, course, and relation_ ships of the fistula tract, the absence or presence of bowel continuity or distal obstruction, the nature of the bowel adjacent to the fistula, and the absence or presence of an abscess cavity in communication with the fistula (see Fig 7-5). Phase2:Investigation 61

62 Phase2:Investigation 62

63 These details will help determine whether surgical intervention will be necessary as well as aid in the planning of such a procedure. The early films, without a lot of dye, give the most information. Computed tomography is most useful in the early management of patients with fistulas to identify abscesses and guide percutaneous interventions. Fistula tracts are not usually visible on axial CT imaging, although sagittal or reconstructed images may provide useful information. Barium contrast upper gastrointestinal studies and enemas rarely provide additional information. Phase2:Investigation 63

64 Phase3:Decision Ideally, provision of a period of sepsis-free nutrition will result in closure of enterocutaneous fistulas within 4-6 weeks. Spontaneous closure of fistulas restores intestinal continuity and allows resumption of oral nutrition. Unfortunately, complex fistulas undergo spontaneous closure in only one-third of cases. Therefore, once resuscitation,wound care, and nutritional support are assured, a decision must be made regarding the likelihood of spontaneous closure of a specific fistula. Information obtained from imaging investigations provides anatomic details about the fistula, while the specifics of the clinical course of the patient, including weight gain, improvement in nutritional parameters, and decrease in fistula output provide prognostic details. 64

65 Fistulograms demonstrating fistulas arising from diseased bowel, in proximity to large abscesses,in settings of disruption of intestinal continuity, in the presence of distal obstruction, and those with short tracts (less than 2 cm) are unlikely to close without operative intervention. Similarly, fistulas originating in the stomach, ileum, or near the ligament of Tieitz have lower rates of spontaneous closure. In contrast,fistulas arising from biliary, pancreatic, or jejunal sources are more likely to resolve spontaneously (seeTable 7-2). Fistulas associated with inflammarory bowel disease often close with nonoperative management only to reopen upon resumption of enteral nutrition. Phase3:Decision 65

66 Fistula tract characteristic 66

67 These fistulas should be formally resected once closed to prevent recurrence. Fistulas in the setting of malignancy or irradiated bowel are particularly resistant to closure and would suggest the need for earlier operative in_ tervention. The timing of operative intervention for fistulas that are unlikely to or fail to close is important. Early operation is indicated to control sepsis not amenable to percutaneous intervention. These early procedures are typically limited to drainage of abscess and resection of phlegmona with definitive resection of fistulas deferred until the patient can be nutritionally and physiologically optimized. Phase3:Decision 67

68 The common practice of waiting at least 4-6 weeks for definitive operative management of enterocutaneous fistulas is based on several factors. First,90-95% of fistulas that will spontaneous close typically do so within 5 weeks of the original operatisn. Furthermore, operation during the first 10 days to 6 weeks from diagnosis of postoperative fistulas is made more difficult by the "obliterative peritonitis" described by Fazio and associates. In this series, reoperations within 10 days of or delayed at least 6 weeks from the original procedure resulted in mortality rates of l3% and 11%, respectively. Phase3:Decision 68

69 In contrast, patients undergoing reoperations between l0 days and 6 weeks of the original laparotomy suffered a mortality rate of 26%. Additionally, delaying operative intervention allows for nutritional support and normalization of serum albumin and transferrin, while delay also allows resolution of local abdominal wound sepsis and preparation of the abdominal wall for secure closure. Optimally, if operation is required, 4 months should elapse from the last operative procedure because the adhesions will have matured and will be easier to deal with after that interval. Phase3:Decision 69

70 Phase4:definitive manegment Just as the initial management and diagnosis of patients with gastrointestinal cutaneous fistulas is time- and labor intensive, the definitive operative reconstruction of these complicated patients requires the commitment of significant time and resources. The surgical team should expect to be in the operating room for up to 7 or 8 hours. The patient should have achieved optimal nutritional parameters and be free of all signs of sepsis. 70

71 Through careful management of fistula drainage, a well-healed abdominal wall without inflammation should be present. Prophylactic antibiotics should be administered based on the patient's previous microbiological data, and tube feedings should be tapered in the days preceding operation to allow mechanical and antibiotic preparation of the bowel. The operation should commence through a new incision distant from any potential sources of inflammation or infection. Often, a transverse incision offers the best opportunity to enter the abdomen in an area free of adhesions. Phase4:definitive manegment 71

72 If the prior midline incision musr be used,entering the abdomen either above or below the limits of the previous incision reduces the risk of inadvertent entry into adherent bowel. Wound towels dipped in antibiotic solution or wound protectors should be used to prevent contamination of the abdominal wall tissues during the course o[the operation. Dissection to free the entire length of the bowel from the ligament of Theiz to the rectum is termed bowel refunctionalization. Refunctionalization identifies and allows resection of all areas of abscess and all sources of obstruction, thus ensuring the best possible chance of avoiding failure of the present operation. Dissection commences in the areas of least dense adhesions. Phase4:definitive manegment 72

73 Use of antibiotic-soaked laparotomy pads on areas of dense adhesions often creates edema that aids in further dissection. Use of the scalpel and scissors to sharply dissect adhesions prevents inadvertent damage to the bowel, as does approaching adhesions from the side, rather than head-on. Careful attention to dissection and closure of all enterotomies in the manner of Heineke-Mikulicz and serosal tears with Lembert sutures of 5_0 Prolene provides the patient with the best possible outcome. Resection of the bowel involved in the fistula is preferred over bypass, Roux-en-Y drainage, or simple serosal patching, although these approaches may be necessary in extreme cases. Phase4:definitive manegment 73

74 Bowel anastomosis should be performed using a two_layer, interrupted, end-to-end anastomosis with nonabsorbable sutures in healthy bowel. Avoiding tension and ensuring adequate blood supply are principles of sound surgical practice that must be followed in these difficult reoperative cases. Both throughout and following the steps of dissection,resection, and anastomosis, frequent irrigation of the abdominal cavity with antibiotic solution should be performed,and constant vigilance for inadvertent bowel injrry should be maintained. Phase4:definitive manegment 74

75 For duodenal fistulas,however, if operation is required, a direct attack on the fistula is less wise. Instead a gastrojejunostomy, with or without vagotomy, with gastrostomy, jejunostomy, and drainage is most likely to give a successful result. Placement of a flap of omentum between the fresh anastomosis and the abdominal wall closure may prevent recurrence of fistulization. Use of Seprafilm may be an adjuvant therapy to aid in prevention of complications from future adhesions. Phase4:definitive manegment 75

76 Consideration of Placement of a decompressive gastrostomy using a no 20 whistle-tip catheter obviates the need for prolonged postoperative nasogastric tube placement in the event of prolonged ileus, which may be expected. Nasogastric tubes are uncomfortable and may interfere with ambulation and pulmonary toilet. Similarly,placement of a feeding jejunostomy may also aid in the postoperative care of patients undergoing procedures of this scale. Abdominal wall closure is the final operative step in the management of patients with enterocutaneous fistulas and is of utmost importance in preventing recurrence. If the abdominal wall has recovered from the previous inflammation and sepsis, a primary closure may be possible. Phase4:definitive manegment 76

77 f a difficult closure is anticipated, a complex myocutaneous flap procedure may be required.The involvement of the plastic and recons_ tructive surgical service is advised under these circumstances and the use of a fresh team will maximize the likelihood of a good outcome for the patient. As the cumulative experience with complex laparoscopic procedures has increased, several groups have reported laparoscopic approaches to enteric and enterocutaneous fistulas. Phase4:definitive manegment 77

78 Phase 5:healing Whether closure of fistulas occurs spontaneously or through operative management, contimration of support is necessary to avoid recurrence. Nutritional support via tube feedings should be continued until the patient is consistently tolerating at least 1500 kilocalories per day orally. Healing of the surgical wound and anastomoses requires a positive nitrogen balance to avoid breakdown of newly formed proteins. Oral feeding typically commences 1 week postoperatively with a soft diet, rather than with the traditional progression from clear liquids to full liquids. The patient's family and nutritional support staff will play an important role in providing foods that are appealing to the patient, as it is often difficult to persuade these patients to eat. 78

79 Zinc supplementation may improve patients' sense of taste and increase oral intake. Similarly, cycling tube feedings overnight may stimulate hunger and increase food intake during the day. Delayed complications continue to be a risk for fistula patients even after healing of their fistulas. Postoperative complications such as anastomotic stricture and adhesive small bowel obstruction, as well as short-bowel syndrome due to multiple resections and recurrence of Fistuli_ zation may all impede patient recovery. Phase 5:healing 79

80 While reoperation in these patients remains a challenge, standard surgical principles should be followed in decision making and performance of any further procedures. Physical and occupational therapists play a role throughout each patient's hospitalization, but their efforts become even more important during the healing phase as the focus shifts to reintroducing the patient to normal activities of daily living. Phase 5:healing 80

81 Involvement of case management staff early in the patient's course will identify obstacles to the patient's successful reintroduction to an active lifestyle,while use of psychiatric consultation-liaison services will identify and address issues of depression and adaptive disorders. Finally, active involvement by the senior surgeon responsible for the patient's care to ensure a coherent treatrnent plan and adequate communication with the patient and family will help avoid confusion and fear while dealing with these challenging cases. One complication not widely reported is the inability of these patients to think clearly and have appropriate decision making. Phase 5:healing 81

82 This is particularly important for business owners and highly-placed executives. This is likely due to protein depletion in the brain. This complication normally takes months to resolve. The patient should be reassured that this complication will resolve spontaneously with good nutrition Phase 5:healing 82

83 conclusion Gastrointestinal cutaneous fistulas remain dreaded complications of cancer, inflammatory bowel disease,and general surgical operations. An understanding of the pathophysiology and risk factors for developmenr of these fistulas may minimize their creation as well as provide a sound plan for their management. Early recognition and resuscitation of patients with fistulas combined with control of sepsis and provision of nutritional support may limit associated complications. Investigation into the anatomic and etiological characteristics of each fistula may provide information about the likelihood of spontaneous closure or suggest earlier operative management. 83

84 Careful planning and technique during definitive surgical therapy and the involvement of a multidisciplinary team will provide the best possibility of resolurion of the fistula. Finally, postoperative maintenance of adequate nutrition and physical and emotional support may allow restoration of the patient to a functional and productive role in society and ensures the durability of the repair. conclusion 84

85 85


Download ppt "ENTERIC FISTULAS IN THE NAME OF GOD 1. ENTERIC FISTULAS represent a second group of complex intraperitoneal infectious processes. Mortality remains high,"

Similar presentations


Ads by Google